ITEOS THERAPEUTICS INC (ITOS) Stock Analyst Ratings
NASDAQ:ITOS - Nasdaq - US46565G1040 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 73% to ITOS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.99. This target is 15.8% above the current price.
ITOS was analyzed by 12 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about ITOS.
In the previous month the buy percentage consensus was at a similar level.
ITOS was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-28 | Wedbush | Downgrade | Outperform -> Neutral |
| 2025-05-28 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-05-14 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-05-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-14 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-05-13 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-04-29 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-12-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | Wells Fargo | Initiate | Overweight |
| 2024-08-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-18 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-08-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-16 | Wedbush | Maintains | Outperform |
| 2023-03-16 | JP Morgan | Maintains | Overweight |
| 2022-05-13 | SVB Leerink | Maintains | Outperform |
| 2021-12-13 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-12 | SVB Leerink | Maintains | Outperform |